ZSTK

ZeroStack Corp.
NASDAQFINANCIAL SERVICESASSET MANAGEMENT

Key Statistics

Market Cap
$3.28M
P/E Ratio
EPS
$-43.17
Beta
1.83
52W High
$47.00
52W Low
$1.32
50-Day MA
$3.49
200-Day MA
$7.18
Dividend Yield
Profit Margin
0.00%
Forward P/E
7.89
PEG Ratio

About ZeroStack Corp.

ZeroStack Corp. The company is headquartered in Fort Lauderdale, Florida.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$36.08M
Gross Profit (TTM)$4.26M
EBITDA$-11.54M
Operating Margin-26.30%
Return on Equity-730.00%
Return on Assets-22.10%
Revenue/Share (TTM)$7.05
Book Value$67.47
Price-to-Book0.09
Price-to-Sales (TTM)0.09
EV/Revenue0.139
EV/EBITDA-1.00
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)5.90%
Shares Outstanding$2.43M
Float$1.77M
% Insiders0.00%
% Institutions3.01%

Historical Volatility

HV 10-Day
63.94%
HV 20-Day
108.38%
HV 30-Day
105.44%
HV 60-Day
109.15%
HV Rank

Volatility is currently contracting

Latest News

ZeroStack Announces Results of 2026 Annual and Special Meeting of Shareholders, Provides Phatebo Purchase Orders Update and Announces Closing of Previously Announced Cryptocurrency Financing

Dallas, Texas--(Newsfile Corp. - July 20, 2026) - ZeroStack Corp. (NASDAQ: ZSTK) ("ZeroStack" or the "Company"), the first Nasdaq-listed, AI-focused asset management company, held its 2026 Annual and Special Meeting of Shareholders (the "Meeting"). The final voting results of the proposals submitted to a vote of the Company's shareholders at the Meeting are as follows: Proposal 1: Election of five directors to the board of directors of the Company (the "Board") to hold office until the Company's 2027 Annual Meeting of Shareholders or until their respective successors are duly elected and qualified.

Newsfile Corp7/20/2026Neutral
ZeroStack Corp. Secures Purchase Orders for up to US$14.7 Million of Inventory from Two Pharmaceutical Companies

Toronto, Ontario--(Newsfile Corp. - July 9, 2026) - ZeroStack Corp. (NASDAQ: ZSTK) (the "Company" or "ZeroStack"), the first Nasdaq-listed, AI-focused asset management company, today announced that it has secured pharmaceutical distribution purchase orders for up to approximately US$14.7 million (EUR 12.9 million) of inventory in Germany from two companies (the "Orders"). The Orders are expected to be fulfilled through the Company's wholly owned German subsidiary, Phatebo GmbH ("Phatebo").

Newsfile Corp7/9/2026Neutral
DeFi Dev Corp. Announces Strategic Leadership Transition of DisclaimerCoin (DONT) to Dedicated Ecosystem Team

BOCA RATON, FL, July 08, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first U.S. public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced the strategic transition of leadership for DisclaimerCoin (“DONT”), the world's first publicly traded company-created memecoin, to Daniel Reis-Faria, Chief Executive Officer of Nasdaq-listed ZeroStack Holdings Inc. (Nasdaq: ZSTK), and a dedicated team focused exclusively on growing the DisclaimerCoin ecosystem. The transition represents the next phase in DisclaimerCoin's evolution.

GlobeNewsWire7/8/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ZSTK and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More FINANCIAL SERVICES Stocks

Data last updated: 7/29/2026